HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,862,074 | -26.1% | 4,577,000 | -27.3% | 0.32% | -13.9% |
| Q2 2023 | $5,228,415 | +10.0% | 6,295,000 | +12.3% | 0.37% | +9.9% |
| Q1 2023 | $4,752,818 | -13.6% | 5,608,000 | -1.3% | 0.33% | -4.3% |
| Q4 2022 | $5,501,857 | +11.5% | 5,683,000 | -2.6% | 0.35% | +5.4% |
| Q3 2022 | $4,936,000 | -59.1% | 5,833,000 | -57.4% | 0.33% | -56.4% |
| Q2 2022 | $12,068,000 | +218.3% | 13,677,000 | +214.4% | 0.76% | +266.7% |
| Q1 2022 | $3,791,000 | – | 4,350,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |